Nantong Guangyuan Chemical 南通广源化工

上海市科学技术进步奖 · Third Prize · 2008

A prestigious government science award granted by the Shanghai Municipal People's Government. Awarded for the project "New Process for the Cyclic Peptide Drug Eptifibatide" — recognizing a breakthrough in cyclic peptide manufacturing that improved synthesis efficiency and yield for this critical antiplatelet drug.

质量管理体系认证 · Certified by SGS

The international gold standard for quality management systems. Issued by SGS — the world's largest inspection, verification, and certification company. This certifies that every stage of production, from raw materials to final product, follows documented, audited quality procedures.

职业健康安全管理体系认证 · GB/T 28001

An internationally recognized workplace safety standard. This certification proves the facility maintains rigorous health and safety management systems to protect workers — a requirement for responsible pharmaceutical manufacturing and chemical handling operations.

环境管理体系认证 · GB/T 24001 · Issued by CAC

The global standard for environmental management. Certified by CAC (China Quality Certification Centre), this confirms the facility meets strict environmental protection requirements — including proper waste disposal, emission controls, and sustainable manufacturing practices for chemical production.

药品生产许可证 · Valid through 2025

An official government-issued license required to legally manufacture pharmaceutical products in China. Issued by provincial FDA-equivalent authorities, it certifies the facility meets GMP (Good Manufacturing Practice) standards for producing Active Pharmaceutical Ingredients (APIs). Only facilities that pass rigorous government inspections receive this license. GYC's Binhai subsidiary also holds its own separate Pharmaceutical Production License.

药品生产许可证 · Binhai (滨海)

A separate Pharmaceutical Production License held by GYC's Binhai subsidiary. This confirms the company operates multiple GMP-compliant production facilities — expanding manufacturing capacity while maintaining the same strict government-regulated quality standards across all sites.

上海市专利工作试点企业 · 2014

A title awarded by the Shanghai Intellectual Property Bureau to companies demonstrating exceptional patent activity and innovation. This recognizes GYC's strong portfolio of proprietary peptide synthesis technologies and original pharmaceutical research — showing the company actively develops and protects its own intellectual property.

高新技术企业证书 · National Level · 2017

A highly selective national-level designation jointly administered by China's Ministry of Science & Technology, Ministry of Finance, and State Taxation Administration. Companies must demonstrate significant R&D investment, proprietary intellectual property, and cutting-edge technological capabilities. Only ~7% of applicants qualify — confirming GYC operates at the frontier of pharmaceutical science.

上海市科技小巨人企业 · 2018

An elite designation from the Shanghai Municipal Commission of Science and Technology, awarded to fast-growing technology companies with exceptional innovation capability and market competitiveness. "Little Giant" enterprises are recognized as future industry leaders — companies that punch far above their weight in technological output relative to their size.

创新型企业 · 2012

Awarded jointly by Shanghai's Commission of Economy and Information, Commission of Science and Technology, and Finance Bureau. This government-backed title recognizes enterprises that have built innovation into their core business strategy — with proven track records of developing novel products, processes, and technologies in pharmaceutical chemistry.